Bracco’s commitment to
research and innovation
Achievements & milestones
2020s
The individuals who appear are for illustrative purposes. All persons depicted are models and not real patients or healthcare professionals.
2022: FDA approves a new macrocyclic GBCA
2020: FDA approves expanded indication for Bracco’s first macrocyclic GBCA
2010s
The individuals who appear are for illustrative purposes. All persons depicted are models and not real patients or healthcare professionals.
2012: Swiss Medical Care acquisition expands automated systems offering, launching Bracco Injeneering business unit
2012, 2018: FDA approves expanded indications for Bracco’s linear GBCA
2016: First to obtain FDA approval for a barium-based product for contrast radiography
2019: Blue Earth Diagnostics is acquired by Bracco Group, expanding nuclear oncology offerings
2000s
The individuals who appear are for illustrative purposes. All persons depicted are models and not real patients or healthcare professionals.
2001: Acquires Acist Medical Systems Inc., a leader in diagnostic and interventional contrast technologies
2001: Discovers a breakthrough contrast agent based on sulfur hexafluoride microbubbles
2004: FDA approves Bracco’s first linear GBCA
2008: Acquires E-Z-EM, Inc., a major manufacturer of contrast media and medical devices for gastrointestinal (GI) radiology
1990s
The individuals who appear are for illustrative purposes. All persons depicted are models and not real patients or healthcare professionals.
1994: Acquires Squibb Diagnostics in the U.S.
1994: Bracco Diagnostics Inc. founded in Princeton, NJ
1980s
All images shown are representative images from referenced studies. Individual results may vary.
1989: FDA approves a new radioactive diagnostic agent for Cardiac PET imaging
1960s
The individual who appears is for illustrative purposes. The person depicted is a model and not a real healthcare professional.
Discovers Iodamide X-ray contrast agent Synthesizes Iopamidol
Sustainable business
principles and standards
-
We at the Bracco Group are aware of our influence on the economic and social well-being of the community.
-
We place the concept of sustainability—expressed economically, environmentally, and socially—at the heart of our operations.
-
We act in accordance with the highest ethical standards.
Social responsibility:
The Fondazione Bracco
Creating opportunities for women and young people around the world reinforces our corporate commitment to our communities in three main areas: art, social cohesion, and science.
Explore further
Our business
Learn more
We are Bracco Diagnostics
Learn more
Speak with a
Bracco account
representative
US-CG-2200009 05/23